Psilocybin Therapy Offers Hope for Burned-Out Health Care Workers

December 6, 2024

VA to Fund First Psychedelic Therapy Study for Veterans Since 1960s

December 6, 2024

NRx Pharmaceuticals Appoints Michael Abrams as CFO

December 2, 2024

Cybin’s Psilocybin Therapy Shows 100% Patient Response in Depression Study

November 21, 2024

Vermont Working Group Says Psychedelics Need More Research

November 20, 2024

A Bright Future for Psychedelics Under Trump?

November 13, 2024